Mark Zuckerberg's philanthropic venture unveils AI world model for drug discovery

Biohub, a venture by Mark Zuckerberg and Priscilla Chan, has launched a protein biology world model. This advanced AI tool aims to speed up drug discovery. The model learns from evolutionary data to understand protein functions. Researchers have already used it to design new protein binders for cancer and immune targets.